LIPTAK VINCENT PAUL enters BLOSSOMHILL THERAPEUTICS, INC. with 106.71K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 8/7/2026ACC: 0002143905-26-000002
Officer· General Counsel
Since Aug 2026
106.71K
Baseline shares
100% direct
106.71K
Direct ownership
1 position
22.69K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned106.71K
Total
106.71K direct106.71K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 106.71K | Direct |
| Total | 106.71K | 106.71K direct |
Derivative Holdings1
Series B Preferred Stock
IndirectUnderlying security
Common Stock
Underlying shares
22.69K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
22.69K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Series B Preferred Stock Indirect | Common Stock | — | — | 22.69K | N/A | |
| Total | 22.69K | 0.00 | ||||